We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Reciprocal repression between P53 and TCTP.
- Authors
Amson, Robert; Pece, Salvatore; Lespagnol, Alexandra; Vyas, Rajesh; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Rodrigues-Ferreira, Sylvie; Wynendaele, Jessika; Chaloin, Olivier; Hoebeke, Johan; Marine, Jean-Christophe; Di Fiore, Pier Paolo; Telerman, Adam
- Abstract
Screening for genes that reprogram cancer cells for the tumor reversion switch identified TCTP (encoding translationally controlled tumor protein) as a crucial regulator of apoptosis. Here we report a negative feedback loop between P53 and TCTP. TCTP promotes P53 degradation by competing with NUMB for binding to P53-MDM2-containing complexes. TCTP inhibits MDM2 auto-ubiquitination and promotes MDM2-mediated ubiquitination and degradation of P53. Notably, Tctp haploinsufficient mice are sensitized to P53-dependent apoptosis. In addition, P53 directly represses TCTP transcription. In 508 breast cancers, high-TCTP status associates with poorly differentiated, aggressive G3-grade tumors, predicting poor prognosis (P < 0.0005). Tctp knockdown in primary mammary tumor cells from ErbB2 transgenic mice results in increased P53 expression and a decreased number of stem-like cancer cells. The pharmacological compounds sertraline and thioridazine increase the amount of P53 by neutralizing TCTP's action on the MDM2-P53 axis. This study links TCTP and P53 in a previously unidentified regulatory circuitry that may underlie the relevance of TCTP in cancer.
- Subjects
TUMOR proteins; APOPTOSIS inhibition; P53 protein; LABORATORY mice; CANCER cells; PHYSIOLOGY
- Publication
Nature Medicine, 2012, Vol 18, Issue 1, p91
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm.2546